Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Triangle (HCTI) Shares Outstanding (Weighted Average) (2020 - 2025)

Healthcare Triangle's Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $4.4 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 21394.55% year-over-year to $4.4 million; the TTM value through Sep 2025 reached $4.4 million, up 21394.55%, while the annual FY2024 figure was $5.3 million, 26.3% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $4.4 million at Healthcare Triangle, up from $1.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $36.0 million in Q3 2022 and bottomed at $20674.0 in Q3 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $4.5 million (2024), against an average of $14.2 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) crashed 99.51% in 2024 before it surged 21394.55% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $29.4 million in 2021, then crashed by 87.43% to $3.7 million in 2022, then grew by 12.99% to $4.2 million in 2023, then rose by 26.3% to $5.3 million in 2024, then fell by 15.81% to $4.4 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Shares Outstanding (Weighted Average) are $4.4 million (Q3 2025), $1.2 million (Q2 2025), and $9.8 million (Q1 2025).